Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights
Graedler, U., Fuchss, T., Ulrich, W.R., Boer, R., Strub, A., Hesslinger, C., Anezo, C., Diederichs, K., Zaliani, A.(2011) Bioorg Med Chem Lett 21: 4228-4232
- PubMed: 21684157
- DOI: https://doi.org/10.1016/j.bmcl.2011.05.073
- Primary Citation of Related Structures:
3NW2 - PubMed Abstract:
Inducible arginine oxidation and subsequent NO production by correspondent synthase (iNOS) are important cellular answers to proinflammatory signals. Prolonged NO production has been proved in higher organisms to cause stroke or septic shock. Several classes of potent NOS inhibitors have been reported, most of them targeting the arginine binding site of the oxygenase domain. Here we disclose the SAR and the rational design of potent and selective iNOS inhibitors which may be useful as anti-inflammatory drugs.
Organizational Affiliation:
Nycomed GmbH, Byk-Gulden-Str. 2, D-78467 Konstanz, Germany. ugraedler@hotmail.com